LEADER 02061nam0 2200433 i 450 001 VAN00114830 005 20240806100752.643 017 70$2N$a978-4-431-55900-9 100 $a20180213d2016 |0itac50 ba 101 $aeng 102 $aJP 105 $a|||| ||||| 200 1 $aGroup-sequential clinical trials with multiple co-objectives$fToshimitsu Hamasaki ... [et al.] 210 $a[Tokyo]$cSpringer$d2016 215 $aIX, 113 p.$cill.$d24 cm 410 1$1001VAN00113968$12001 $aSpringerBriefs in Statistics. JSS research series in statistics$1210 $aBerlin [etc.]$cSpringer$d2015- 500 1$3VAN00242415$aGroup-sequential clinical trials with multiple co-objectives$91523375 606 $a62K05$xOptimal statistical designs [MSC 2020]$3VANC033803$2MF 606 $a62P10$xApplications of statistics to biology and medical sciences; meta analysis [MSC 2020]$3VANC024649$2MF 606 $a92-XX$xBiology and other natural sciences [MSC 2020]$3VANC020839$2MF 606 $a92B15$xGeneral Biostatistics [MSC 2020]$3VANC026442$2MF 606 $a92C50$xMedical applications (general) [MSC 2020]$3VANC027825$2MF 610 $aGroup sequential designs$9KW:K 610 $aInterim Analysis$9KW:K 610 $aMultiple endpoints$9KW:K 610 $aNoninferiority$9KW:K 610 $aSample Size Recalculation$9KW:K 610 $aSample size calculation$9KW:K 620 $dTokyo$3VANL000048 702 1$aHamasaki$bToshimitsu$3VANV088857 712 $aSpringer $3VANV108073$4650 801 $aIT$bSOL$c20240906$gRICA 856 4 $uhttp://dx.doi.org/10.1007/978-4-431-55900-9$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth 899 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15 912 $fN 912 $aVAN00114830 950 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS SBA EBOOK 2289 $e15EB 2289 20180213 996 $aGroup-sequential clinical trials with multiple co-objectives$91523375 997 $aUNICAMPANIA